RecruitingPhase 2NCT07073820
A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489
Studying Heritable pulmonary arterial hypertension
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Pfizer
- Principal Investigator
- Pfizer CT.gov Call CenterPfizer
- Intervention
- PF-07868489(drug)
- Enrollment
- 36 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2025 – 2028
Study locations (22)
- Heart and Vascular Center, San Francisco, California, United States
- University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
- Clinical Trials Unit at Eastowne Medical Office Building, Chapel Hill, North Carolina, United States
- Pulmonary Specialty Clinic at Eastowne Medical Office Building, Chapel Hill, North Carolina, United States
- Rhode Island Hospital, Providence, Rhode Island, United States
- Center for Advanced Lung Care, Providence, Rhode Island, United States
- Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
- London Health Sciences Centre - University Hospital, London, Ontario, Canada
- Shanghai Pulmonary Hospital, Shanghai, Shanghai Municipality, China
- Vseobecna fakultni nemocnice v Praze, Prague, Czechia
- CHRU de Brest, Brest, Finistère, France
- Thoraxklinik-Heidelberg gGmbH, Heidelberg, Baden-Wurttemberg, Germany
- Universitätsklinikum Regensburg, Regensburg, Bavaria, Germany
- University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári, Attica, Greece
- AHEPA University General Hospital of Thessaloniki, Thessaloniki, Central Macedonia, Greece
- +7 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07073820 on ClinicalTrials.govOther trials for Heritable pulmonary arterial hypertension
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07498244Collagen Fingerprinting for Stratification of Pulmonary Hypertension (PH) PatientsMedical University of Graz
- RECRUITINGNANCT07079592A Deep-Learning-Enabled Electrocardiogram for Detecting Pulmonary HypertensionNational Defense Medical Center, Taiwan
- RECRUITINGPHASE4NCT07147114Clinical Trial to Evaluate the Efficacy and Safety in Concomitant Administration of Macitentan and Dapagliflozin in Patients With Heart Failure With Mildly Reduced and Preserved Ejection Fraction (HFmrEF and HFpEF) and Combined Pre- and Post-capillary Pulmonary Hypertension (CpcPH)Gachon University Gil Medical Center
- RECRUITINGNCT07537517Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension.Hospital General Universitario Gregorio Marañon
- RECRUITINGNANCT07120789Validation of a Patient Knowledge Questionnaire for Pulmonary HypertensionUniversity of Sao Paulo General Hospital
- RECRUITINGNANCT07576894Right Ventricular Response to Exercise Among Patients With Chronic Obstructive Pulmonary DiseaseUniversity of Colorado, Denver
- RECRUITINGNCT07087613Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECGEko Devices, Inc.
- RECRUITINGNANCT06850792imprOving Adherence to Pulmonary artErial hyperteNsion Treatment With teLemedicIne and patieNt guidaNceUniversity of Sao Paulo General Hospital
See all trials for Heritable pulmonary arterial hypertension →